Sanofi said it would halt development of its vaccine against Covid-19 based on mRNA technology despite it having showed positive early-stage trial results.
赛诺菲(Sanofi)表示将停止对基于mRNA技术的新冠疫苗的研发，尽管该公司已经在早期试验中取得了积极成果。
您已阅读10%（210字），剩余90%（1802字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。